6. Septa| Link| Bookmark|
November 30, 2015 10:12:25 AM
(4000+ Posts, 4600+ Likes)
Rs. 540-550 per share, with discount of Rs. 15 per share being offered to retail quota. IPO will remain open for subscription between 8th Dec to 10th Dec
Aiming to tap the upbeat investor sentiments, two companies Alkem Laboratories and Dr Lal Pathlabs will hit the capital markets next week, to raise an estimated Rs 2,000 crore through IPOs.
The bidding for shares in the initial public offers (IPOs) may open between December 8 and 10.
In addition, Health Care Global Enterprises and Infibeam Incorporation are looking to the hit capital markets.
These companies are planning to launch their initial share sale plans by December 15, as foreign institutional investors are not active during holidays season.
agree bottomline is grown it is in growth industry but still the valuation is very very very steep so it is avoid btw it is not a bogus issue ha ha ha ha
Septa, do not cross ur limits. Be decent when others too are. When I posted this comment, the price was not yet decided. I found the company to be good based on its strength, yr on yr growth prospectus, etc. So shut up ur big mouth. Please see my profile and the messages that I have posted for earlier IPOs. Don''t act like an ...hole. Just don''t label people based on ur narrow minded view.
sorry rajeev however i never used any bad word i just said how do u find 50 pe attractive without any analysis that is reason i said may be a paid stooge if ur not it is okay however pls tell us why u think 50 PE is fine understand that u do not like ALKEM at 30 PE bcoz of ifs and buts anyway i am sorry BTW i have not acted a xxxhole thought an investor is bullish on 50 PE and not on 30PE sound fishy and that to in same sector anyway my comment r not immature however ur reaction is very very immature.... i agree to disagree for me on these valuation in AVOID. based on data available
BTW after placing my first comment i checked ur pervious comment and i agree u have contributed before in many IPO boards still ur bullish on LAL and Bearish on ALKEM made me think...
BTW still now we do not know the actual price band issue size dilution actual PE..... let forgive and forget and be mature enough to agree to disagree
Septa, its ok but don''t call anyone paid stooge w/o proper reason. I am still bullish on Dr LPL. Let''s see. I have to still go into details. But overall looking at it a glace, it still looks good. Look at gross sales to profit. Its expansion plans plus the lifestyle of the population demographic of India. What do u feel? Is it too expensive? Even for Indigo, future prospectus and its business model carried it through.
LAL could be good company but is it a good investment... at 50 plus PE it is avoid in my books for me any company with more then 30 PE is avoid anyway best of luck
2.9. Eagleye| Link| Bookmark|
December 24, 2015 9:25:02 PM
IPO Guru (6600+ Posts, 22000+ Likes)